Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-051667
Filing Date
2010-03-10
Accepted
2010-03-09 20:34:54
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1054872
2 STOCK PURCHASE AGREEMENT dex1025.htm EX-10.25 61330
3 SUBSIDIARIES OF DARA BIOSCIENCES, INC. dex21.htm EX-21 3408
4 CONSENT OF ERNST & YOUNG LLP dex23.htm EX-23 1442
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6609
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6561
7 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5418
8 GRAPHIC g76668tx_pg3.jpg GRAPHIC 39354
  Complete submission text file 0001193125-10-051667.txt   1195689
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 10668542
SIC: 2834 Pharmaceutical Preparations